Liver venous deprivation (LVD) enhances outcomes versus portal vein embolization (PVE) among liver cancer patients needing preoperative liver augmentation. LVD significantly boosts future liver remnant growth by 24.57% and daily volume by 4.30%. It shortens surgery wait times by over 5 days and operation duration by nearly 43 minutes. Resection completion rates improve by 73%, […]
Category: HPB & Spleen
Adherence to BCLC Guidelines Boosts Survival in HCC
Real-world adherence to BCLC treatment guidelines in hepatocellular carcinoma significantly impacts patient survival. Overall adherence was only 47.8%, with the best rates (93.5%) in stage D and the lowest (23.1%) in stage C. Patients following BCLC recommendations lived longer: 722 days versus 535 days for non-adherents. Improving adherence, especially in early and advanced stages, is […]
Multifocal Cholangiocarcinoma: Rethinking Prognosis
Surgeons need to reconsider the staging of multifocal intrahepatic cholangiocarcinoma as all cases should be classified as AJCC stage III, impacting surgical decision-making. Patients with multifocal tumors showed worse overall survival (26.1 vs. 60.0 months) and disease-free survival (9.8 vs. 25.0 months) compared to solitary tumors of stage II. Genomic profiling revealed that both satellite […]
Improved Liver Segmentation Enhances Surgical Planning
Surgeons can refine liver surgery strategies with a new patient-specific segmentation method focused on vascular structures. This new hepatic and portal vein-based classification (hpvc) showed better anatomical alignment than conventional methods, particularly for complex liver segments 5 and 8. Surgeons rated hpvc higher in accuracy for surgical planning and anatomical adherence compared to traditional classifications […]
Mastering Robotic Liver Resection: Frequency Matters
Frequent access to robotic platforms leads to better outcomes in liver resection. Conversion rate was 10.8%, with significant variance in blood loss based on imm grade: 184 ml (grade 1), 381 ml (grade 2), 753 ml (grade 3). Competency was achieved faster by surgeons with high-frequency access (35 cases vs. 47 cases). Structured training and […]
Anatomical Resection Cuts Early Recurrence in HCC Patients
Anatomical resection can significantly reduce early recurrence rates in select hepatocellular carcinoma patients. In patients with tumors ≤5 cm and non-smooth margins, anatomical resection led to a 16.76% absolute reduction in early recurrence risk. Patients with these characteristics showed improved recurrence-free survival compared to non-anatomical resection. Identifying patients with specific radiological features can optimize surgical […]
Innovative Two-Stage Hepatectomy for Intrahepatic Cholangiocarcinoma
Surgeons can safely resect complex liver tumors using a novel two-stage approach that minimizes ischemic injury. Combining total vascular exclusion with veno-venous ECMO and hypothermic perfusion led to negative margins in a patient with unresectable intrahepatic cholangiocarcinoma. Operative time was 4 hours and 3 minutes, with 72 minutes of hypothermic perfusion and 130 minutes of […]
Fewer Endocrine Complications with Completion Pancreatectomy
Completion pancreatectomy reduces severe endocrine complications compared to total pancreatectomy. Total pancreatectomy patients face a 2.9-fold increase in endocrine issues during the first year post-surgery. Risk of hypoglycemia is 3.0 times higher, while diabetic ketoacidosis risk is 9.3 times greater in total pancreatectomy patients. Surgeons should consider completion pancreatectomy for better endocrine outcomes and enhance […]
Effective Nonsurgical Strategy for Benign Biliary Strictures
Magnetic compression anastomosis offers a promising option for patients with completely obstructed benign biliary strictures unresponsive to standard therapies. 92.9% overall success rate in 113 patients treated with MCA. Only 14.3% experienced recurrence, with a median of 23.7 months after treatment. Surgeons can consider MCA as a viable alternative, minimizing the need for surgical interventions. […]
Endoscopic Ultrasound Outperforms PTBD for Biliary Obstruction
Endoscopic ultrasound (EUS) is a cost-effective strategy for managing malignant distal biliary obstruction (MDBO) after failed ERCP, leading to better outcomes. EUS-guided biliary drainage (EUS-GB) cost $14,520, yielding 0.38 QALYs and an incremental net monetary benefit (NMB) of $37,768. EUS-guided choledochoduodenostomy (EUS-CBD) cost $17,694, providing 0.55 QALYs and an incremental NMB of $52,171. EUS techniques […]
